Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aquila Corporation is a U.S. medical device company focused on wheelchair cushion systems for the prevention and healing support of pressure sores and pressure ulcers. Its lead commercial product is the SofTech alternating-pressure wheelchair cushion, an FDA-cleared Class II device marketed to wheelchair users, clinicians, and rehabilitation providers. Historically, the company also marketed the Airpulse PK wheelchair cushion system and related seating products. Aquila appears to operate as a small, specialized manufacturer in the rehab and durable medical equipment market rather than as a drug-development biotech company. Its business is centered on customized seating, pressure management, and support services such as product consultation and Medicare or insurance guidance.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aquila Corporation.